terprenin derivatives (Shionogi)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameterprenin derivatives (Shionogi)
Drug Alias Nameterprenin
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShionogi & Co Ltd
Active IndicationsN/A
Inactive IndicationsHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A